We are proud to share that Freyr’s expertise in Decentralized Clinical Trials (DCTs) has been featured in Clinical Leader. In his article, Balaji Maddiboyina discusses how sponsors can align with the FDA’s 2024 Final Guidance to optimize DCT strategies and enhance patient-centric approaches.